Journal
Pulmonary Circulation
Publication Date
1-1-2024
Volume
14
Issue
1
First Page
e12352
Document Type
Open Access Publication
DOI
10.1002/pul2.12352
Rights and Permissions
Gillies H, Chakinala MM, Dake BT, Feldman JP, Hoeper MM, Humbert M, Jing Z-C, Langley J, McLaughlin VV, Niven RW, Rosenkranz S, Zhang X, Hill NS. IMPAHCT: A randomized phase 2b/3 study of inhaled imatinib for pulmonary arterial hypertension. Pulm Circ. 2024; 14:e12352. https://doi.org/10.1002/pul2.12352 © 2024 The Authors. Pulmonary Circulation published by Wiley Periodicals LLC on behalf of the Pulmonary Vascular Research Institute. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Recommended Citation
Gillies, Hunter; Chakinala, Murali M; Dake, Benjamin T; Feldman, Jeremy P; Hoeper, Marius M; Humbert, Marc; Jing, Zhi-Cheng; Langley, Jonathan; McLaughlin, Vallerie V; Niven, Ralph W; Rosenkranz, Stephan; Zhang, Xiaosha; and Hill, Nicholas S, "IMPAHCT: A randomized phase 2b/3 study of inhaled imatinib for pulmonary arterial hypertension." Pulmonary Circulation. 14, 1. e12352 (2024).
https://digitalcommons.wustl.edu/oa_4/5721
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
